Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Gunther Laukien in 1960 and is headquartered in Billerica, MA. |  |
|
| ChairmanDr. Frank H. Laukien Ph.D. Executive VP & CFOMr. Gerald N. Herman CPA Corporate Executive VP and President of Bruker Nano Group & CorporateDr. Mark R. Munch Ph.D. President of Bruker CALID Group & Bruker Daltonics DivisionMr. Juergen W. Srega President of Bruker BioSpin GroupDr. Falko Busse Ph.D. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| MARK R MUNCH | Officer | Jun 15 '26 | Proposed Sale | 54.76 | 2,000 | 109,520 | | Jun 15 04:38 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | May 15 '26 | Option Exercise | 22.19 | 2,000 | 44,380 | 130,443 | May 18 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | May 15 '26 | Sale | 43.90 | 2,000 | 87,800 | 128,443 | May 18 04:15 PM | | MARK R MUNCH | Officer | May 15 '26 | Proposed Sale | 43.90 | 2,000 | 87,800 | | May 15 04:07 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Apr 15 '26 | Option Exercise | 22.19 | 2,000 | 44,380 | 130,443 | Apr 16 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Apr 15 '26 | Sale | 39.90 | 2,000 | 79,800 | 128,443 | Apr 16 04:15 PM | | MARK R MUNCH | Officer | Apr 15 '26 | Proposed Sale | 39.90 | 2,000 | 79,800 | | Apr 15 04:08 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Mar 13 '26 | Option Exercise | 22.19 | 2,000 | 44,380 | 130,443 | Mar 16 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Mar 13 '26 | Sale | 35.44 | 2,000 | 70,880 | 128,443 | Mar 16 04:15 PM | | MARK R MUNCH | Officer | Mar 13 '26 | Proposed Sale | 35.44 | 2,000 | 70,880 | | Mar 13 04:19 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Feb 13 '26 | Option Exercise | 22.19 | 2,000 | 44,380 | 130,443 | Feb 18 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Feb 13 '26 | Sale | 36.94 | 2,000 | 73,880 | 128,443 | Feb 18 04:15 PM | | MARK R MUNCH | Officer | Feb 13 '26 | Proposed Sale | 36.94 | 2,000 | 73,880 | | Feb 13 04:28 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 15 '26 | Option Exercise | 22.19 | 2,000 | 44,380 | 130,443 | Jan 16 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 15 '26 | Sale | 49.20 | 2,000 | 98,400 | 128,443 | Jan 16 04:15 PM | | MARK R MUNCH | Officer | Jan 15 '26 | Proposed Sale | 49.20 | 2,000 | 98,400 | | Jan 15 04:01 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 12 '26 | Option Exercise | 22.19 | 7,000 | 155,330 | 135,443 | Jan 13 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 12 '26 | Sale | 55.00 | 7,000 | 385,000 | 128,443 | Jan 13 04:15 PM | | MARK R MUNCH | Officer | Jan 12 '26 | Proposed Sale | 55.00 | 7,000 | 385,000 | | Jan 12 04:07 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 05 '26 | Option Exercise | 22.19 | 33,843 | 750,976 | 162,286 | Jan 06 04:15 PM | | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Jan 05 '26 | Sale | 49.66 | 33,843 | 1,680,647 | 128,443 | Jan 06 04:15 PM | | MARK R MUNCH | Officer | Jan 05 '26 | Proposed Sale | 49.66 | 33,843 | 1,680,704 | | Jan 05 04:09 PM | | PACKER RICHARD A | Director | Dec 01 '25 | Option Exercise | 24.00 | 10,000 | 240,000 | 94,202 | Dec 02 04:15 PM | | PACKER RICHARD A | Director | Dec 01 '25 | Sale | 48.38 | 5,028 | 243,230 | 89,174 | Dec 02 04:15 PM | | RICHARD A PACKER | Director | Dec 01 '25 | Proposed Sale | 48.38 | 5,028 | 243,230 | | Dec 01 04:14 PM | | ORNELL JOHN A | Director | Nov 06 '25 | Option Exercise | 24.00 | 10,000 | 240,000 | 41,445 | Nov 10 04:43 PM | | ORNELL JOHN A | Director | Nov 06 '25 | Sale | 39.00 | 6,233 | 243,087 | 35,212 | Nov 10 04:43 PM | | JOHN ORNELL | Director | Nov 06 '25 | Proposed Sale | 39.01 | 6,233 | 243,121 | | Nov 06 04:10 PM | | Friend Cynthia M | Director | Sep 12 '25 | Option Exercise | 26.17 | 4,300 | 112,531 | 21,551 | Sep 12 04:15 PM | | Friend Cynthia M | Director | Sep 12 '25 | Sale | 32.25 | 3,535 | 113,990 | 18,016 | Sep 12 04:15 PM | | CYNTHIA FRIEND | Director | Sep 12 '25 | Proposed Sale | 32.25 | 3,535 | 113,990 | | Sep 12 04:01 PM |
|
